Get the Stockscreener App
73.38
2.41%
1.73
Solventum Corp stock is traded at $73.38, with a volume of 1.68M.
It is up +2.41% in the last 24 hours and up +12.46% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$71.65
Open:
$71.86
24h Volume:
1.68M
Relative Volume:
1.28
Market Cap:
$12.71B
Revenue:
$8.35B
Net Income/Loss:
$1.56B
P/E Ratio:
8.2693
EPS:
8.8738
Net Cash Flow:
$-4.00M
1W Performance:
+10.13%
1M Performance:
+12.46%
6M Performance:
+2.60%
1Y Performance:
+10.13%
1-Day Range:
$71.50
$73.40
1-Week Range:
$66.26
$73.40
52-Week Range:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
73.38 | 12.71B | 8.35B | 1.56B | -4.00M | 8.8738 |
ISRG
Intuitive Surgical Inc
|
450.06 | 159.39B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
149.43 | 41.17B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
39.52 | 33.42B | 29.14B | 1.07B | 1.52B | 1.1995 |
ALC
Alcon Inc
|
62.56 | 30.51B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
206.76 | 29.99B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-26 | Initiated | Rothschild & Co Redburn | Sell |
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Why Solventum (SOLV) Is Up 6.4% After Reaffirming 2026 Outlook Despite Softer Q1 Results – And What's Next - simplywall.st
Solventum stock is recovering: What's going on? - MSN
Solventum Q1 FY26 slides: EPS beats forecast, margins expand to 19.5% - Investing.com India
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Earnings call transcript: Solventum Q1 2026 earnings beat expectations - Investing.com UK
Earnings call transcript: Solventum Q1 2026 earnings beat expectations By Investing.com - Investing.com Canada
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum (SOLV) tops Q1 earnings and revenue estimates - MSN
Research Alert: CFRA Maintains Hold On Shares Of Solventum Corporation - Moomoo
Solventum executives take the stage at BofA health conference May 13 - Stock Titan
Solventum to Participate in the 2026 BofA Securities Health Care Conference - marketscreener.com
Wells Fargo Keeps Their Hold Rating on Solventum Corporation (SOLV) - The Globe and Mail
Solventum Bets On 20 Product Launches To Power Post-3M Growth - Citeline News & Insights
Solventum Beats Consensus Estimates for 1Q26 - Medical Device and Diagnostic industry
Solventum (SOLV) Q1 Earnings Slump As Margin Compression Tests Bullish Narratives - simplywall.st
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates - Zacks Investment Research
UBS Adjusts Price Target on Solventum to $78 From $82, Maintains Neutral Rating - marketscreener.com
Solventum (SOLV) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance
Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
Solventum : Shareholder Letter Q1 2026 - marketscreener.com
Research Alert: Solventum: Broad-based Q1 Growth, Guidance Maintained - Moomoo
Solventum: Q1 Earnings Snapshot - theheraldreview.com
SOLV Q1 Deep Dive: Portfolio Moves and Product Launches Shape Year Ahead - FinancialContent
Solventum Q1 FY26 slides: earnings beat amid portfolio transformation By Investing.com - Investing.com India
Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune
Solventum Corporation Q1 2026 Financial Results and Highlights – SEC 10-Q Filing - Minichart
Assessing Solventum (SOLV) Valuation After Recent Share Price Rebound And Product Pipeline Progress - simplywall.st
Solventum Earnings Call Signals Margin Momentum Ahead - TipRanks
Solventum posts Q1 sales, adjusted EPS beats - MassDevice
Solventum outlines EPS toward high end of $6.40-$6.60 range while expecting $100M-$120M annual tariff headwinds - MSN
Solventum Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Solventum forecasts annual profit at higher end on wound care demand - WHTC
Solventum Q1 FY26 slides: earnings beat amid portfolio transformation - Investing.com
Transcript : Solventum Corporation, Q1 2026 Earnings Call, May 05, 2026 - marketscreener.com
Solventum : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Solventum’s Wound-Care Demand Lifts Profit Outlook, Not Its Stock - Finimize
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Solventum (SOLV) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Solventum Q1 2026 Earnings Call: Complete Transcript - Benzinga
Solventum Corp 1Q 2026: Revenue $2.01B, Net income $13M, EPS $0.07— 10-Q Summary - TradingView
Profits slide as Solventum (NYSE: SOLV) faces tariffs, restructuring and weak cash flow - Stock Titan
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum Corporation 2026 Q1ResultsEarnings Call Presentation (NYSE:SOLV) 2026-05-05 - Seeking Alpha
Solventum Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Solventum Q1 Adjusted Earnings Rise, Sales Decline - marketscreener.com
Solventum : Quarterly Financial Update Q1 2026 - marketscreener.com
Solventum (NYSE:SOLV) Exceeds Q1 CY2026 Expectations - StockStory
Solventum Corp (NYSE:SOLV) Shares Flat After Q1 Beat - ChartMill
SOLVENTUM ($SOLV) Releases Q1 2026 Earnings - Quiver Quantitative
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):